Business Segments · Restructuring Reserve
Oncology & Multispecialty — Restructuring Reserve
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026
Rolls up toRestructuring Reserve
How to read this metric
An increase suggests upcoming cost-cutting or organizational shifts; a decrease suggests the completion of restructuring activities.
Detailed definition
The total accrued liability set aside for future costs related to organizational restructuring, such as severance, facil...
Peer comparison
Standard liability disclosure for companies undergoing operational transformation.
Metric ID:
mck_segment_oncology_multispecialty_restructuring_reserveHistorical Data
3 periods
| Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $3.00M | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — |
| YoY Change | — | -100.0% | — |
Range$0.00 – $3.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — restructuring reserve?
- McKesson (MCK) reported oncology & multispecialty — restructuring reserve of $0.00 in Q1 2026.
- What does oncology & multispecialty — restructuring reserve mean?
- Funds set aside to cover the costs of future business reorganization.